Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.

BMC pregnancy and childbirth - 25 Feb 2014

Kent Julie, Farrell Anne-Maree, Soothill Peter

Abstract excerpt

BACKGROUND: Since its introduction in the 1960s Anti-D immunoglobulin (Anti-D Ig) has been highly successful in reducing the incidence of haemolytic disease of the fetus and newborn (HDFN) and achieving improvements to maternal and fetal health. It has protected women from other invasive interventions during pregnancy and prevented deaths and damage amongst newborns and is a technology which has been adopted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Hemolytic
Share to Fetal Blood
Share to Injections, Intravenous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isoantibodies

Share to Practice Guidelines as Topic

Share to Rh-Hr Blood-Group System

Share to Rh Isoimmunization

Share to Rho(D) Immune Globulin

Source

Open in PubMed Open full text

Identifiers

PMID: 24568571
DOI: 10.1186/1471-2393-14-87
PMCID: PMC3944436

Genes

RHD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.PMID 24568571Read ↗

A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.Semantic proximity Read ↗

Anti-D prophylaxis: past, present and future.Semantic proximity Read ↗

Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time.Semantic proximity Read ↗

No. 343-Routine Non-invasive Prenatal Prediction of Fetal RHD Genotype in Canada: The Time is Here.Semantic proximity Read ↗

RHD genotyping from maternal plasma: guidelines and technical challenges.Semantic proximity Read ↗

Routine testing of fetal Rhesus D status in Rhesus D negative women using cell-free fetal DNA: an investigation into the preferences and information needs of women.Semantic proximity Read ↗

Non-invasive foetal RhD genotyping: A strategy for rationalizing anti-D immunoglobulin prophylaxis in RhD-negative pregnant women at the Hospital Italiano de Buenos Aires.Semantic proximity Read ↗

Routine noninvasive prenatal screening for fetal Rh D in maternal plasma-A 2-year experience from a single center in Belgium.Semantic proximity Read ↗

Management of red cell alloimmunisation in pregnancy: the non-invasive monitoring of the disease.Semantic proximity Read ↗

Prenatal screening service for fetal RHD genotyping to guide prophylaxis: the two-year experience of the Friuli Venezia Giulia region in Italy.Semantic proximity Read ↗

Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women.Semantic proximity Read ↗

Non-invasive fetal RHD genotyping in the first trimester of pregnancy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.